货号:A723745
同义名:
Eutannin; NSC 69862
Chebulinic acid是一种有效的结核分枝杆菌DNA旋转酶的天然抑制剂,也可抑制SMAD-3磷酸化和H+ K+-ATPase活性。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | DNA synthesis ↓ ↑ | helicase ↓ ↑ | RdRp ↓ ↑ | ribonucleotide reductase ↓ ↑ | tRNA synthetase ↓ ↑ | YB-1 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fexinidazole | ✔ | 98% | |||||||||||||||||
| Daptomycin | ✔ | 98% | |||||||||||||||||
| Blasticidin S·HCl | ✔ | 98% | |||||||||||||||||
| Metronidazole | ✔ | 98% | |||||||||||||||||
| Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM |
98% | |||||||||||||||||
| Triglycidyl isocyanurate | ✔ | p53 | 98+% | ||||||||||||||||
| Nedaplatin | ✔ | 99%+ | |||||||||||||||||
| Oxolinic acid | ✔ | 98+% | |||||||||||||||||
| Bendamustine | ✔ | 98+% | |||||||||||||||||
| Trifluridine | ✔ | 98% | |||||||||||||||||
| Robinetin | ✔ | 99%+ | |||||||||||||||||
| Carboplatin | ✔ | 99% | |||||||||||||||||
| Cidofovir | ✔ | 99% | |||||||||||||||||
| Cisplatin | ✔ | 99% | |||||||||||||||||
| Cytarabine |
++++
DNA synthesis, IC50: 16 nM |
98% | |||||||||||||||||
| Acelarin |
++++
DNA synthesis, EC50: 0.2 nM |
99%+ | |||||||||||||||||
| Oxaliplatin | ✔ | 98% | |||||||||||||||||
| YK-4-279 | ✔ | 99%+ | |||||||||||||||||
| ML216 |
+
BLMfull-length, IC50: 2.98 μM BLM636-1298, IC50: 0.97 μM |
99%+ | |||||||||||||||||
| RK-33 | ✔ | 98% | |||||||||||||||||
| Brr2-IN-3 | ✔ | 99%+ | |||||||||||||||||
| Phen-DC3 Trifluoromethanesulfonate | ✔ | 95% | |||||||||||||||||
| Favipiravir | ✔ | 99% | |||||||||||||||||
| Suramin sodium salt |
++
RdRp, IC50: 0.26 μM |
99%+ | |||||||||||||||||
| Clofarabine |
++
Ribonucleotide reductase, IC50: 65 nM |
97% | |||||||||||||||||
| Didox | ✔ | 98% | |||||||||||||||||
| (E)-3-AP | ✔ | 99% | |||||||||||||||||
| Halofuginone |
+++
prolyl-tRNA synthetase, Ki: 18.3nM |
99%+ | |||||||||||||||||
| BC-LI-0186 |
+++
Leucyl-tRNA synthetase, Kd: 42.1 nM Leucyl-tRNA synthetase, IC50: 46.11 nM |
98% | |||||||||||||||||
| SU056 |
+
YB-1, IC50: 1.73 μM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | ATPase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (-)-Blebbistatin | 99%+ | ||||||||||||||||||
| PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
99% | |||||||||||||||||
| Esomeprazole sodium | ✔ | 98% | |||||||||||||||||
| BTB06584 | ✔ | 99% | |||||||||||||||||
| Ciclopirox | ✔ | 97% | |||||||||||||||||
| CB-5083 |
++++
p97 AAA ATPase, IC50: 11 nM |
99%+ | |||||||||||||||||
| Ciclopirox olamine | ✔ | 99% | |||||||||||||||||
| Brefeldin A |
+++
ATPase (HCT 116), IC50: 0.2 μM |
99%+ | |||||||||||||||||
| Oligomycin A | ✔ | 99% | |||||||||||||||||
| Sodium orthovanadate |
+++
(Na,K)-ATPase, IC50: 40 nM |
25-28%V | |||||||||||||||||
| Golgicide A | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | Topo I ↓ ↑ | Topo II ↓ ↑ | Topo IV ↓ ↑ | Topoisomerase ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ellagic acid | ✔ | 98% | |||||||||||||||||
| β-Lapachone | ✔ | 99%+ | |||||||||||||||||
| (s)-10-hydroxycamptothecin | ✔ | 98+% | |||||||||||||||||
| Camptothecin |
++
Topo I, IC50: 0.68 μM |
98% | |||||||||||||||||
| Betulinic acid |
++
Eukaryotic topoisomerase I, IC50: 5 μM |
98% | |||||||||||||||||
| Topotecan |
++++
Topo I (MCF-7 Luc cells), IC50: 13 nM Topo I (DU-145 Luc cells), IC50: 2 nM |
98% | |||||||||||||||||
| Irinotecan HCl Trihydrate | ✔ | 98% | |||||||||||||||||
| SN-38 | ✔ | 98% | |||||||||||||||||
| Levofloxacin hydrate | ✔ | 98% | |||||||||||||||||
| Dexrazoxane | ✔ | 99%+ | |||||||||||||||||
| Ofloxacin | ✔ | 98+% | |||||||||||||||||
| Enoxacin | ✔ | 99%+ | |||||||||||||||||
| Flumequine |
+
Topo II, IC50: 15 μM |
98% | |||||||||||||||||
| Levofloxacin | ✔ | 97% | |||||||||||||||||
| Etoposide | ✔ | 98% | |||||||||||||||||
| Pefloxacin mesylate dihydrate | ✔ | 99.5% | |||||||||||||||||
| Marbofloxacin | ✔ | 98+% | |||||||||||||||||
| Voreloxin HCl | ✔ | 98% | |||||||||||||||||
| Mitoxantrone 2HCl | ✔ | PKC | 98% | ||||||||||||||||
| Nalidixic acid | ✔ | 98% | |||||||||||||||||
| Doxorubicin | ✔ | 97% | |||||||||||||||||
| Novobiocin sodium | ✔ | 95% | |||||||||||||||||
| Amonafide | ✔ | 99%+ | |||||||||||||||||
| Pirarubicin | ✔ | 98%+ | |||||||||||||||||
| Idarubicin HCl |
+++
Topo II (MCF-7 cells), IC50: 3.3 ng/mL |
99%+ | |||||||||||||||||
| Genistein | ✔ | EGFR | 98% | ||||||||||||||||
| Teniposide | ✔ | 98% | |||||||||||||||||
| Moxifloxacin | ✔ | 98% | |||||||||||||||||
| Ciprofloxacin | ✔ | 98% | |||||||||||||||||
| Clinafloxacin | ✔ | 99% | |||||||||||||||||
| Gatifloxacin | ✔ | 98% | |||||||||||||||||
| Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM |
98% | |||||||||||||||||
| Epirubicin HCl | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Chebulinic acid is a potent natural inhibitor of M. tuberculosis DNA gyrase, also can inhibit SMAD-3 phosphorylation and H+ K+-ATPase activity. |
| Concentration | Treated Time | Description | References | |
| Pseudomonas aeruginosa | 10 µM | 4 h | Inhibit PG-hydrolyzing activity of Mpg orthologs | mBio. 2025 Apr 9;16(4):e0402724 |
| Neisseria gonorrhoeae | 1 µM | 22 h | Inhibit Mpg enzymatic activity, reduce T4p expression | mBio. 2025 Apr 9;16(4):e0402724 |
| Staphylococcus aureus | 10 µM | 4 h | Inhibit PG-hydrolyzing activity of LytM1 and G-G endopeptidase | mBio. 2025 Apr 9;16(4):e0402724 |
| Vibrio cholerae | 10 µM | 4 h | Significantly inhibit PG-hydrolyzing activity of Mpg orthologs | mBio. 2025 Apr 9;16(4):e0402724 |
| Escherichia coli | 10 µM | 4 h | Significantly inhibit PG-hydrolyzing activity of Mpg orthologs | mBio. 2025 Apr 9;16(4):e0402724 |
| Acinetobacter baumannii | 10 µM | 4 h | Significantly inhibit PG-hydrolyzing activity of Mpg orthologs | mBio. 2025 Apr 9;16(4):e0402724 |
| 3T3-L1 preadipocytes | 5, 10, 20 μM | 8 days | Chebulinic acid significantly inhibited the differentiation of 3T3-L1 preadipocytes into adipocytes and reduced lipid droplet accumulation in a concentration-dependent manner. 20 μM Chebulinic acid suppressed lipid accumulation by >60%. | Int J Mol Sci. 2022 Jan 13;23(2):865 |
| LLC-PK1 cells | 0, 12.5, 25, 50 µM | 24 h | Evaluate the inhibitory effect of Chebulinic acid on PEDV replication, showing significant reductions in viral genome, viral protein, and titer. | Front Cell Infect Microbiol. 2025 Mar 18;15:1531415 |
| CCL-81 cells | 0, 12.5, 25, 50 µM | 24 h | Evaluate the inhibitory effect of Chebulinic acid on PEDV replication, showing significant reductions in viral genome, viral protein, and titer. | Front Cell Infect Microbiol. 2025 Mar 18;15:1531415 |
| Human synovial microvascular endothelial cells (HSMECs) | 1.7 μM | To investigate the effects of Chebulinic acid on VEGF-induced phosphorylation of Erk1/2, p38 MAPK, and Akt. Results showed that Chebulinic acid significantly inhibited VEGF-induced phosphorylation of these signaling pathways. | Arthritis Res Ther. 2020 Nov 23;22(1):273 | |
| Helicobacter pylori ATCC 700392 | 16-32 μg/mL | 6 h | Evaluated the anti-adhesive effect of Chebulinic acid on Helicobacter pylori, showing significant inhibition of bacterial adhesion at 16 or 32 μg/mL. | Front Microbiol. 2024 Oct 2;15:1416794 |
| GES-1 | 64 μg/mL | 24 h | Assessed the cytotoxicity of Chebulinic acid on GES-1 cells, showing no significant effect on cell viability at 64 μg/mL. | Front Microbiol. 2024 Oct 2;15:1416794 |
| HeLa cells | 100 µM | 90 min | Evaluate the effect of Chebulinic acid on the respiratory capacity of HeLa cells, showing no significant inhibition of respiratory capacity. | Theranostics. 2021 Mar 5;11(11):5077-5091 |
| Administration | Dosage | Frequency | Description | References | ||
| DBA/1J mice | Collagen-induced arthritis (CIA) model | Oral gavage | 50 mg/kg | Once daily for 14 consecutive days | To evaluate the effects of Chebulinic acid on disease progression in CIA mice. Results showed that Chebulinic acid significantly inhibited paw swelling, decreased the mean articular index and joint pathology scores, and did not increase blood pressure. | Arthritis Res Ther. 2020 Nov 23;22(1):273 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.05mL 0.21mL 0.10mL |
5.23mL 1.05mL 0.52mL |
10.45mL 2.09mL 1.05mL |
|
| CAS号 | 18942-26-2 |
| 分子式 | C41H32O27 |
| 分子量 | 956.68 |
| SMILES Code | O=C(O)C[C@@H]([C@](C1=C(O2)C(O)=C(O)C=C1C3=O)([H])[C@@H](O)C2=O)C(O[C@]4([H])[C@@H](COC(C5=CC(O)=C(O)C(O)=C5)=O)O[C@@H](OC(C6=CC(O)=C(O)C(O)=C6)=O)[C@]([C@@H]4OC(C7=CC(O)=C(O)C(O)=C7)=O)([H])O3)=O |
| MDL No. | MFCD06656295 |
| 别名 | Eutannin; NSC 69862 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(109.75 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1